Claims for Patent: 10,568,859

Summary for Patent: 10,568,859

Title:	Topical foam composition
Abstract:	The present invention relates to a novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and acute skin conditions, particularly acne and psoriasis; and processes for preparing the emulsion aerosol foam compositions. In particular, the present invention relates to oil in water emulsion aerosol foam compositions containing a retinoid in the oil phase.
Inventor(s):	Loupenok; Leon (Rowville, AU)
Assignee:	MAYNE PHARMA LLC (Greenville, NC)
Application Number:	12/711,337
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,568,859
Patent Claims:	1. An oil in water emulsion aerosol foam composition comprising an oil phase and a water phase, said composition comprising: i) tazarotene, ii) water in an amount from about 65% to about 90% by weight, iii) an oil present in an amount from about 1% to about 9% by weight, wherein the oil is selected from the group consisting of azulene, chamazulene, isoparaffin, linear alpha olefins, cyclohexlidenediphenyl methane, didecene, diethylhexylcydohexane, eicosane, isododecane, isoeicosane, isohexadecane, longifolene, mineral oil, light mineral oil, paraffin, pentahydrosqualene, petrolatum, squalane, squalene, tetradecene, and mixtures thereof, iv) an oil miscible organic solvent selected from the group consisting of diisopropyl adipate, isopropyl myristate, octyl dodecanol, caprylic/capric triglycerides, and mixtures thereof, v) a surfactant component comprising from about 1% to about 8% by weight of a surfactant selected from the group consisting of ceteareth-12, oleth-10, and a mixture thereof, and vi) a propellant selected from the group consisting of hydrocarbon propellants and mixtures thereof, wherein the tazarotene is solubilized in the oil phase of the composition, wherein the particle size of the oil phase is less than about 1000 nm, and wherein all percentages are based on the total weight of the composition. 2. The aerosol foam composition according to claim 1, wherein the composition comprises water in an amount from about 70% to about 85% by weight. 3. The aerosol foam composition according to claim 2, wherein the oil is light mineral oil. 4. The aerosol foam composition according to claim 3, wherein the light mineral oil is present in an amount from about 3% to about 8% by weight. 5. The aerosol foam composition according to claim 1, wherein the oil miscible organic solvent is diisopropyl adipate. 6. The aerosol foam composition according to claim 4, wherein the surfactant comprises ceteareth-12. 7. The aerosol foam composition according to claim 6, wherein the surfactant is present in amount from about 2% to about 6% by weight. 8. An oil in water emulsion aerosol foam composition comprising an oil phase and a water phase, said composition comprising: i) tazarotene; ii) water in an amount from about 70% to about 85% by weight; iii) an oil present in an amount from about 3% to about 8% by weight, wherein the oil is light mineral oil; iv) an oil miscible organic solvent present in an amount from about 3% to about 15% by weight, wherein the oil miscible organic solvent is diisopropyl adipate; v) a surfactant component comprising from about 2% to about 6% by weight of a hydrophilic ethoxylated fatty alcohol ether, wherein the hydrophilic ethoxylated fatty alcohol ether is ceteareth-12 vi) a propellant selected from the group consisting of hydrocarbon propellants and mixtures thereof, wherein the tazarotene is solubilized in the oil phase of the composition, wherein the particle size of the oil phase is less than about 1000 nm, and wherein all percentages are based on the total weight of the composition. 9. A method of treating a skin disease, disorder or condition, comprising administering to the skin of a patient requiring such treatment an effective amount of a composition according to claim 8. 10. The aerosol foam composition according to claim 8, further comprising a preservative that is a combination of sorbic acid and a salt thereof. 11. The aerosol foam composition according to claim 8, wherein the mean particle size of the oil phase is about 100 nm. 12. The aerosol foam composition according to claim 8, wherein the surfactant component consists of ceteareth-12. 13. The aerosol foam composition according to claim 1, wherein the surfactant component consists of ceteareth-12, oleth-10, or a mixture thereof. 14. The aerosol foam composition according to claim 1, wherein the composition is chemically and physically stable regardless of whether any other surfactant component besides ceteareth-12, oleth-10, or a mixture thereof also is present. 15. The aerosol foam composition according to claim 13, wherein the surfactant component consists of ceteareth-12, or a mixture of ceteareth-12 and oleth-10.